Determination and optimization of the mechanism of action for efficacy of Gleevec in the type I diabetes NOD mouse model

-
Investigator: Jeffrey A. Bluestone, PhD
Sponsor: Genomics Inst of the Novartis Resrch Fdn

Location(s): United States

Description

no description available